GE Healthcare
©2010 General Electric Company – All rights reserved.
General Electric Company reserves the right to make changes in specifications and
features shown herein, or discontinue the product described at any time without
notice or obligation.
GE, GE Monogram, Alcyone, ASiR, Discovery, and SnapShot are trademarks of
General Electric Company.
GE Healthcare, a division of General Electric Company.
Lead the way.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our broad expertise
in medical imaging and information technologies, medical diagnostics,
patient monitoring systems, drug discovery, biopharmaceutical
manufacturing technologies, performance improvement and performance
solutions services helps our customers to deliver better care to more people
around the world at a lower cost. In addition, we partner with healthcare
leaders, striving to leverage the global policy change necessary to
implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join
us on our journey as we continuously develop innovations focused on
reducing costs, increasing access, and improving quality around the world.
Headquartered in the United Kingdom, GE Healthcare is a unit of General
Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are
committed to serving healthcare professionals and their patients in more
than 100 countries. For more information about GE Healthcare, visit our
website at www.gehealthcare.com
Molecular Imaging
GE Healthcare
3000 N. Grandview Blvd.
Waukesha, WI 53188
U.S.A.
www.gehealthcare.com
imagination at work
MI-0131-08.10-EN-us
Biomarker Development
Regulatory Compliance
Workflow Efficiency
Tracer Distribution
Pre-Clinical Imaging
Physician Education
Clinical Imaging
Keep ahead of the curve
in molecular imaging.
The future of diagnostic imaging lies in the
smallest functional unit of human life.
By examining molecular processes and
pathways using radio-labeled biomarkers,
molecular imaging helps you identify
specific pathologies and assess function.
Combined with anatomical imaging in
PET/CT and SPECT/CT, it helps you
localize disease more precisely to make
better treatment decisions.
Molecular imaging is understanding
disease. From the beginning.
It aligns perfectly with GE Healthcare’s
healthymagination commitment to improve
healthcare quality, cost, and access
everywhere. And it opens up endless
exciting clinical and research possibilities.
Despite all the challenges of starting or
growing your molecular imaging capabilities,
at GE we help make molecular imaging
easier and more accessible. From drug
development to helping you fight disease
with advanced imaging for oncology,
cardiology, and neurology, we alone offer
you the total solution of technology,
products, and services to support you
along the molecular imaging pathway.
We lead the industry with the world’s
largest installed base of molecular
imaging research and clinical equipment,
and a long heritage of proven products
and results. Collaborating with you,
we can help you build the competency,
confidence, and expertise to realize your
vision of molecular imaging.
We make it easier to think big about
seeing small.
Discover
Set a course to what lies ahead.
“If we can develop
techniques where we
can detect just a few
thousand cells, or
even a few hundred
thousand cells, we can
catch disease much
earlier and then change
the outcome for the
patient and possibly
even cure diseases.”
Sanjiv Sam Gambhir
MD, PhD
Director, Molecular
Imaging Program
at Stanford University
Understanding disease from the beginning starts
in the research lab.
Much like the microscope opened new vistas to
early scientists, researchers today use GE Healthcare
Molecular Imaging technology to develop drugs, assay
specific life processes, and unravel complex interactions
in pre-clinical and clinical models. Our cutting-edge
tools empower researchers to lead their field by
developing novel studies in this growing area of
diagnostic imaging. With more than 80 years’ experience
in chemistry and radiopharmaceuticals, GE Healthcare
is a pioneer in tracer development and distribution.
Our molecular isotope research and development
yield targeted agents for molecular imaging diagnosis,
to help you better understand disease.
To help expand the reach of molecular imaging,
we simplify the complexities of radiopharmacy and
radiotracer production with one complete, singletouch-point infrastructure solution that provides full
end-to-end capabilities. TRACERcenter-GMP combines
equipment, information, and services to help you
establish and operate your own clinical research PET
tracer development center or commercial diagnostic
PET radiopharmacy.
In addition, our robust FASTlab is an economical,
flexible, automated solution to the ever-evolving
challenges of tracer production.
GE PET/CT imaging systems are used in targeted
therapeutic drug clinical trials for early assessments
of tested drugs. The foundation for many molecular
imaging breakthroughs, our pre-clinical research
capability promotes the development of new
therapeutics and tracers by using the newest
imaging technologies and disease models.
Did you know?
With seven or more development compounds in
clinical trials at any one time, GE’s portfolio of new
molecular imaging agents is unrivaled.
Did you know?
With over 80 years of experience in medical
imaging technology, GE Healthcare is #1 in
installed base systems in PET/CT, SPECT/CT,
and cyclotrons worldwide.
Care
A more confident hold on patient health.
“If the development
of new treatments
can be merged with
developments in
diagnostics, we will
have an impact on
patient management,
which I think is the
end game here.”
Bengt Långström
Professor
Uppsala University, Sweden
Imperial College, UK
Odense University Hospital,
Denmark
GE Healthcare Molecular Imaging empowers you,
as a clinician, with the tools to solve the tough clinical
challenges you face daily in cardiology, neurology,
and oncology disease management.
In Nuclear Medicine, GE Healthcare’s Alcyone
technology reveals cardiac anatomy and pathology
with greater clarity and speed, for shorter scan
times and better dose management.
The challenge is to detect small lesions to catch
disease early. Stage and localize disease precisely.
Accurately evaluate responses to therapy. Reduce
diagnostic dilemmas to improve treatments. And
make confident, well-informed clinical decisions to
better manage patient care.
First to market with PET/CT, GE Healthcare continues
its leadership. By capturing detail and precision even
in areas of the body subject to respiratory motion, our
PET/CT systems give you more information to help you
diagnose and stage cancer with accuracy, plan with
precision, and monitor with confidence.
Molecular imaging helps you do all of this. GE Healthcare
Molecular Imaging offerings can help guide treatment
planning of your most complex and difficult cases,
while streamlining your clinical workflow. Our innovative
scanner systems and relevant clinical applications
in both Nuclear Medicine and PET/CT help you set
yourself apart from your peers by providing
remarkable advanced technology for your patients.
Offering fresh vision into understanding disease,
our flexible Discovery™ PET/CT 600 Series systems
offer you the most relevant choices in advanced
PET/CT capabilities and performance. Designed to
excel in both clinical implementation and imaging
exploration, this platform helps deliver greater
precision for higher diagnostic confidence and better
clinical decision making.
Did you know?
The GE TRACERcenter-GMP is the only solution that
offers all of the expertise—from quality assurance
and regulatory, to service support—needed to
implement PET imaging centers worldwide.
Grow
From the tiniest of molecules, huge opportunity.
“The increase to our
department’s efficiency
due to the upgrade is
impressive! This will
give us an advantage
in our market.”
Jim Madison
Vice President
HCS Group
Addressing the economic aspects of healthcare
in increasingly cost-conscious times can be
daunting. To maximize institutional profit without
compromising patient care, administrators need
reliable, cost-effective equipment backed by
dependable, lifelong service.
GE Molecular Imaging can help you lead your facility
to greater success and prestige. Your investment in
understanding disease from the beginning can make
as big of a difference in your bottom line as it does in
your patient care.
Add economic value to your department or clinic
by offering specialized services that open up new
opportunities in unexplored markets and clinical
areas. With the reliability, upgradability, and
scalability of our molecular imaging solutions,
you’ll be more confident in the return on your
equipment investments. And your capabilities can
easily grow with your changing needs.
We help protect your investment through easy
system upgrades without replacing equipment.
We support you with ongoing software solutions,
training and education, and exposure to world leaders
in molecular imaging. Through GE Healthcare Financial
Services, you have access to flexible, customized
financing solutions that help drive affordability.
The reassurance of strong after-sales service support
is absolutely critical in molecular imaging—and is
exactly what our service offerings provide. From
standard operating needs and industry requirements
to asset management and new clinical informatics,
we help you meet your service priorities.
Did you know?
With the ASiRTM option on the DiscoveryTM NM/CT 570c
and the DiscoveryTM PET/CT 690 systems, the CT dose
to a cardiac patient can be reduced up to 44%* and
with SnapShotTM Pulse up to 83%*.
Prove
“The costs of these
imaging techniques
are definitely much
less than the costs
of surgery, particularly
surgery which will
be futile.”
Homer Macapinlac, MD
Chair, Department of
Nuclear Medicine
The University of Texas
MD Anderson Cancer Center
Rising costs. Limited access. Inconsistent quality.
These and other challenges make healthcare by far
one of the world’s most pressing and complex problems.
Healthymagination is a GE business strategy designed
to address these global healthcare concerns in very
real and relevant ways. The goal: to provide better
healthcare for more people around the world, through
innovations focused on making health sustainable.
To that end, GE Healthcare is committing $6 billion to
launch 100+ innovations by 2015 that are proven to
lower healthcare costs, increase healthcare access,
and improve healthcare quality worldwide by 15%.
Each innovation undergoes a rigorous process of
proof and validation by an independent third-party
source—Oxford Analytica, an international strategic
research firm specializing in monitoring and analysis.
GE Healthcare Molecular Imaging products play a
key role in the healthymagination initiative. With
ASiR (Adaptive Statistical Iterative Reconstruction)
technology, we’ve implemented an improvement in
hybrid system quality through the reduction of CT
dose to the patient without compromising image
quality. Two Molecular Imaging systems–the Discovery
NM/CT 570c and the Discovery PET/CT 690–have
been healthymagination-validated based on ASiR
technology, proof of our commitment to continually
improve the quality of patient care.
* The actual dose reduction level achieved will depend on the application
and physician preference with specific protocols.
Lead the way with
GE Healthcare Molecular Imaging.
Understanding disease.
From the beginning.